Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5716390 | Human Pathology | 2017 | 28 Pages |
Abstract
Glioma is the most common type of malignant neoplasm in the central nervous system, with high incidence and mortality rate. MicroRNAs, as a class of small noncoding RNAs, play an important role in carcinogenesis and correlate with glioma diagnosis and prognosis. In this study, we investigated the microRNA-204 (miR-204) concentration in glioma tissues and its relation to the expression of ezrin and bcl-2 mRNA, as well as its potential predictive and prognostic values in glioma. The concentrations of miR-204 were significantly lower in glioma tissues than in nontumor brain tissues and also were lower in high-grade than in low-grade gliomas (World Health Organization grades III and IV versus grades I and II). The miR-204 concentration was inversely correlated with the ezrin and bcl-2 concentrations. The miR-204 concentration was classified as high or low according to the median value, and low miR-204 correlated with higher World Health Organization grade, larger tumor, and worse Karnofsky performance score. Kaplan-Meier survival analysis demonstrated that patients with low miR-204 expression had shorter progression-free survival and overall survival than patients with high miR-204 expression. In addition, univariate and multivariate analyses showed that miR-204 expression was an independent prognostic feature of overall survival and progression-free survival. In conclusion, our study indicates that miR-204 is downregulated in glioma and may be a biomarker of poor prognosis in patients with this cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Zhen-Nan MD, Jing-Peng MD, Ling-Yun MD, Xiang-Sheng MD, Zong MD, PhD, Qiang MD, Yue MD, Ce-Gang MD, Zi-Huan MD, PhD, Hua-Sheng MD, PhD, Wen-Zhong MD, Chun-Hua MD, PhD,